Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
October 3, 2017

Market Update

Julia Lee
September 29, 2017

Market Update

Julia Lee
September 28, 2017

Your Money Your Call

Julia Lee
September 27, 2017

Market Update

Julia Lee
September 26, 2017

Market Update

Julia Lee
September 25, 2017

Market Update

Julia Lee
September 22, 2017

Market Update

Julia Lee
September 21, 2017

Market Update 18 September 2017

Julia Lee
September 18, 2017

Market Update

Julia Lee
September 13, 2017

Market Update

Julia Lee
September 12, 2017